Variant report
Variant | nsv527547 |
---|---|
Chromosome Location | chrX:29581553-29619671 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:55)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 1)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BRCA1 | chrX:29608540-29608552 | GM12878 | blood: | n/a | n/a |
2 | CEBPB | chrX:29603424-29603592 | A549 | lung: | n/a | n/a |
3 | CTCF | chrX:29593341-29593348 | GM10248 | blood: | n/a | n/a |
4 | CTCF | chrX:29612919-29612976 | Pancreas_OC | pancreas: | n/a | n/a |
5 | CTCF | chrX:29616522-29616550 | LNCaP | prostate: | n/a | n/a |
6 | CTCF | chrX:29606408-29606472 | GM20000 | blood: | n/a | n/a |
7 | CTCF | chrX:29591156-29591193 | GM10248 | blood: | n/a | n/a |
8 | CTCF | chrX:29593260-29593334 | GM10248 | blood: | n/a | n/a |
9 | CTCF | chrX:29616555-29616564 | LNCaP | prostate: | n/a | n/a |
10 | CTCF | chrX:29614749-29614804 | GM20000 | blood: | n/a | n/a |
11 | CTCF | chrX:29615928-29616049 | GM20000 | blood: | n/a | n/a |
12 | CTCF | chrX:29591148-29591233 | GM20000 | blood: | n/a | n/a |
13 | FOS | chrX:29599332-29599583 | HUVEC | blood vessel: | n/a | n/a |
14 | GATA2 | chrX:29599420-29599753 | HUVEC | blood vessel: | n/a | n/a |
15 | GATA3 | chrX:29588620-29588984 | SK-N-SH | brain: | n/a | n/a |
16 | GATA3 | chrX:29588603-29588894 | T-47D | breast: | n/a | n/a |
17 | JUN | chrX:29587954-29588190 | K562 | blood: | n/a | n/a |
18 | MYC | chrX:29593485-29593546 | H1-hESC | embryonic stem cell: | n/a | n/a |
19 | MYC | chrX:29609182-29609247 | H1-hESC | embryonic stem cell: | n/a | n/a |
20 | MYC | chrX:29608640-29608673 | GM12878 | blood: | n/a | n/a |
21 | POLR2A | chrX:29593584-29593624 | A549 | lung: | n/a | n/a |
22 | POLR2A | chrX:29593563-29593570 | A549 | lung: | n/a | n/a |
23 | POLR2A | chrX:29597249-29597338 | ProgFib | skin: | n/a | n/a |
24 | POLR2A | chrX:29611538-29611619 | ProgFib | skin: | n/a | n/a |
25 | POLR2A | chrX:29612109-29612223 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | POLR2A | chrX:29589125-29589214 | HUVEC | blood vessel: | n/a | n/a |
27 | POLR2A | chrX:29616282-29616315 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | POLR2A | chrX:29589074-29589155 | A549 | lung: | n/a | n/a |
29 | POLR2A | chrX:29597292-29597450 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | POLR2A | chrX:29602698-29602874 | K562 | blood: | n/a | n/a |
31 | POLR2A | chrX:29591206-29591399 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chrX:29608698-29608821 | ProgFib | skin: | n/a | n/a |
33 | POLR2A | chrX:29619014-29619081 | A549 | lung: | n/a | n/a |
34 | POLR2A | chrX:29594718-29594857 | ProgFib | skin: | n/a | n/a |
35 | POLR2A | chrX:29598722-29598913 | ProgFib | skin: | n/a | n/a |
36 | POLR2A | chrX:29603662-29603664 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | POLR2A | chrX:29611542-29611631 | HUVEC | blood vessel: | n/a | n/a |
38 | POLR2A | chrX:29609841-29609857 | A549 | lung: | n/a | n/a |
39 | POLR2A | chrX:29608587-29608637 | A549 | lung: | n/a | n/a |
40 | POLR2A | chrX:29611307-29611360 | A549 | lung: | n/a | n/a |
41 | POLR2A | chrX:29583583-29583672 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | POLR2A | chrX:29609613-29609835 | A549 | lung: | n/a | n/a |
43 | POLR2A | chrX:29611300-29611302 | A549 | lung: | n/a | n/a |
44 | POLR2A | chrX:29610957-29610990 | A549 | lung: | n/a | n/a |
45 | POLR2A | chrX:29593629-29593702 | A549 | lung: | n/a | n/a |
46 | POLR2A | chrX:29611379-29611421 | A549 | lung: | n/a | n/a |
47 | POLR2A | chrX:29611264-29611266 | A549 | lung: | n/a | n/a |
48 | RUNX3 | chrX:29605292-29605625 | GM12878 | blood: | n/a | n/a |
49 | STAT3 | chrX:29611771-29611958 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | STAT3 | chrX:29583033-29583150 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
No data |
miRNA name | Chromosome Location | mirBase accession |
---|---|---|
hsa-miR-4666b | chrX:29592403-29592425 | MIMAT0022485 |
No data |
Variant related genes | Relation type |
---|---|
MIR4666B | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183302175 | chrX:29587957-29587958 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs144854086 | chrX:29587973-29587974 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs188518456 | chrX:29587992-29587993 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs5927784 | chrX:29588004-29588005 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs147103367 | chrX:29588605-29588606 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs191526491 | chrX:29588611-29588612 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs183679496 | chrX:29588656-29588657 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs369611543 | chrX:29588824-29588825 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs188057097 | chrX:29588832-29588833 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs6526887 | chrX:29588888-29588889 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs181982065 | chrX:29588894-29588895 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs5927785 | chrX:29589105-29589106 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs201313993 | chrX:29589165-29589166 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs386824508 | chrX:29589174-29589175 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs374953270 | chrX:29589186-29589187 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs386824509 | chrX:29589195-29589196 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs369419809 | chrX:29590994-29590995 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs191481920 | chrX:29591052-29591053 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs112294139 | chrX:29591060-29591061 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs543478038 | chrX:29591118-29591119 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs142669249 | chrX:29591250-29591251 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs113444594 | chrX:29591277-29591278 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs140631495 | chrX:29592425-29592426 | Inactive region | miRNA | n/a | Overlapped CNVs | n/a |
24 | rs187021600 | chrX:29599672-29599673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs191511116 | chrX:29599708-29599709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs76874664 | chrX:29599769-29599770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs79989472 | chrX:29599770-29599771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539196355 | chrX:29599843-29599844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs113859784 | chrX:29599872-29599873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs112548776 | chrX:29599890-29599891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs187508036 | chrX:29599898-29599899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs193281114 | chrX:29599993-29599994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs5927865 | chrX:29605016-29605017 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs57841605 | chrX:29605017-29605018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34857378 | chrX:29605104-29605105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs149430091 | chrX:29605193-29605194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs144698705 | chrX:29605323-29605324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148075493 | chrX:29605378-29605379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs143914324 | chrX:29605407-29605408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs191243947 | chrX:29605464-29605465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs377435065 | chrX:29605485-29605486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs182336224 | chrX:29605496-29605497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs186664357 | chrX:29605507-29605508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs191127720 | chrX:29605525-29605526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs183306778 | chrX:29605634-29605635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs147264109 | chrX:29605678-29605679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs140801693 | chrX:29605784-29605785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs187641833 | chrX:29605866-29605867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs142822181 | chrX:29606057-29606058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs192891229 | chrX:29606092-29606093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 23615299 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Astrocytoma | 17387387 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Schizophrenia | 23904455 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
infertile | 22614455 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Cancer | 20581869 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 20164919 | CNVD |
Premature ovarian failure | 20952765 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Cerebellar hypoplasia | 21569638 | CNVD |
X-linked lissencephaly | 21569638 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17406619 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Mental retardation | 20613765 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Duchenne-like muscular dystrophy | 22470819 | CNVD |
Muscular dystrophy | 22470819 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chrX:29599600-29600000 | Enhancers | Fetal Heart | heart |
2 | chrX:29605000-29606400 | Enhancers | GM12878-XiMat | blood |
3 | chrX:29608600-29609000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chrX:29609000-29609400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chrX:29609400-29610000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chrX:29616800-29617800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chrX:29616800-29618600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chrX:29617000-29618600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chrX:29617000-29619000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chrX:29617000-29619000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chrX:29617600-29618400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chrX:29618400-29618800 | Enhancers | H1 Cell Line | embryonic stem cell |
13 | chrX:29618600-29619200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |